Blinded End Point Adjudication in the ‘Danish Multicenter Randomized Study on Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction’ (DANAMI-2 Trial)

By  

Heart Drug, Vol. 3, Iss. 3, 2003-11 ,pp. : 127-133

Karger

Access to resources Recommend Favorite

The Costs and Benefits of Community Thrombolysis for Acute Myocardial Infarction: A Decision-Analytic Model

By Luke Vale   Harvey Steffens   Cam Donaldson  

PharmacoEconomics, Vol. 22, Iss. 14, 2004-01 ,pp. : 943-954

Adis International

Access to resources Recommend Favorite

For patients with acute anterior wall ST-segment elevation myocardial infarction (STEMI), early abciximab prior to angioplasty improves treatment outcomes

By  

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Utilisation of Thrombolytic Therapy in Older Patients with Myocardial Infarction

By Woods K.L.   Ketley D.  

Drugs & Aging, Vol. 13, Iss. 6, 1998-12 ,pp. : 435-441

Adis International

Access to resources Recommend Favorite

Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East

By Al-Zakwani Ibrahim  

International Journal of Clinical Pharmacy, Vol. 34, Iss. 3, 2012-06 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite